PCVX

Vaxcyte
D

PCVX

49.670
USD
-0.58
(-1.15%)
مغلق
حجم التداول
35,500
الربح لكل سهم
-4
العائد الربحي
-
P/E
-10
حجم السوق
6,502,114,083
الأخبار المقالات

العنوان: Vaxcyte

القطاع: Healthcare
الصناعة: Biotechnology
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to preventor treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.